These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 31201054)
1. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
2. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697 [TBL] [Abstract][Full Text] [Related]
3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
4. Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Shen CF; Guilbault C; Li X; Elahi SM; Ansorge S; Kamen A; Gilbert R Vaccine; 2019 Nov; 37(47):6996-7002. PubMed ID: 31288997 [TBL] [Abstract][Full Text] [Related]
5. Purification of rabies virus produced in Vero cells grown in serum free medium. Trabelsi K; Ben Zakour M; Kallel H Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287 [TBL] [Abstract][Full Text] [Related]
6. High vero cell density and rabies virus proliferation on fibracel disks versus cytodex-1 in spinner flask. Hassanzadeh SM; Zavareh A; Shokrgozar MA; Ramezani A; Fayaz A Pak J Biol Sci; 2011 Apr; 14(7):441-8. PubMed ID: 21902056 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of various serum and animal protein free media for the production of a veterinary rabies vaccine in BHK-21 cells. Kallel H; Jouini A; Majoul S; Rourou S J Biotechnol; 2002 May; 95(3):195-204. PubMed ID: 12007860 [TBL] [Abstract][Full Text] [Related]
8. An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines. Rourou S; Ben Ayed Y; Trabelsi K; Majoul S; Kallel H Vaccine; 2014 May; 32(24):2767-9. PubMed ID: 24583007 [TBL] [Abstract][Full Text] [Related]
9. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor. Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733 [TBL] [Abstract][Full Text] [Related]
10. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
11. An experimental rabies vaccine produced with a new BHK-21 suspension cell culture process: use of serum-free medium and perfusion-reactor system. Perrin P; Madhusudana S; Gontier-Jallet C; Petres S; Tordo N; Merten OW Vaccine; 1995 Sep; 13(13):1244-50. PubMed ID: 8578811 [TBL] [Abstract][Full Text] [Related]
12. Suspension-Vero cell cultures as a platform for viral vaccine production. Paillet C; Forno G; Kratje R; Etcheverrigaray M Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123 [TBL] [Abstract][Full Text] [Related]
13. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-l bioreactor. Kallel H; Rourou S; Majoul S; Loukil H Appl Microbiol Biotechnol; 2003 Jun; 61(5-6):441-6. PubMed ID: 12764557 [TBL] [Abstract][Full Text] [Related]
15. Bioreactor production of rVSV-based vectors in Vero cell suspension cultures. Kiesslich S; Kim GN; Shen CF; Kang CY; Kamen AA Biotechnol Bioeng; 2021 Jul; 118(7):2649-2659. PubMed ID: 33837958 [TBL] [Abstract][Full Text] [Related]
16. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium. Mattos DA; Silva MV; Gaspar LP; Castilho LR Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117 [TBL] [Abstract][Full Text] [Related]
17. Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density. Nie J; Sun Y; Peng F; Han F; Yang Y; Liu X; Liu C; Li Y; Bai Z Biotechnol Lett; 2020 Dec; 42(12):2551-2560. PubMed ID: 32816175 [TBL] [Abstract][Full Text] [Related]
18. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. Arifin MA; Mel M; Abdul Karim MI; Ideris A J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497 [TBL] [Abstract][Full Text] [Related]
19. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods. Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004 [TBL] [Abstract][Full Text] [Related]
20. Higher production of rabies virus in serum-free medium cell cultures on microcarriers. Frazzati-Gallina NM; Paoli RL; Mourão-Fuches RM; Jorge SA; Pereira CA J Biotechnol; 2001 Dec; 92(1):67-72. PubMed ID: 11604174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]